374 related articles for article (PubMed ID: 24793878)
1. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
[TBL] [Abstract][Full Text] [Related]
2. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
[TBL] [Abstract][Full Text] [Related]
3. 3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors.
Takao K; Yahagi H; Uesawa Y; Sugita Y
Bioorg Chem; 2018 Apr; 77():436-442. PubMed ID: 29448189
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
6. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
10. Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.
Chimenti P; Petzer A; Carradori S; D'Ascenzio M; Silvestri R; Alcaro S; Ortuso F; Petzer JP; Secci D
Eur J Med Chem; 2013 Aug; 66():221-7. PubMed ID: 23807114
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides.
Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Befani O; Turini P; Alcaro S; Ortuso F
Bioorg Med Chem Lett; 2006 Aug; 16(15):4135-40. PubMed ID: 16759860
[TBL] [Abstract][Full Text] [Related]
12. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies.
Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A
Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
15. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
17. Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.
Ruan BF; Cheng HJ; Ren J; Li HL; Guo LL; Zhang XX; Liao C
Eur J Med Chem; 2015 Oct; 103():185-90. PubMed ID: 26352677
[TBL] [Abstract][Full Text] [Related]
18. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
20. Chalcones: a valid scaffold for monoamine oxidases inhibitors.
Chimenti F; Fioravanti R; Bolasco A; Chimenti P; Secci D; Rossi F; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 May; 52(9):2818-24. PubMed ID: 19378991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]